# Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

> **NCT00287768** · PHASE3 · COMPLETED · sponsor: **Japan Clinical Cancer Research Organization** · enrollment: 628 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** docetaxel + S-1
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT00287768
- **Lead sponsor:** Japan Clinical Cancer Research Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-09
- **Final completion:** 2010-10
- **Target enrollment:** 628 (ESTIMATED)
- **Last updated:** 2011-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287768, "Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00287768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*